Evommune, Inc.EVMNEarnings & Financial Report
NYSE
NextMar 19, 2026
EVMN Q3 2025 Key Financial Metrics
Revenue
$10.0M
Gross Profit
N/A
Operating Profit
$-13.3M
Net Profit
$-12.5M
Gross Margin
N/A
Operating Margin
-133.3%
Net Margin
-124.8%
YoY Growth
N/A
EPS
$-8.07
Financial Flow
Evommune, Inc. Q3 2025 Financial Summary
Evommune, Inc. reported revenue of $10.0M for Q3 2025, with a net profit of $-12.5M (-124.8% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $10.0M |
|---|---|
| Net Profit | $-12.5M |
| Gross Margin | N/A |
| Operating Margin | -133.3% |
| Report Period | Q3 2025 |
Income Statement
| Q3 2025 | |
|---|---|
| Revenue | $10.0M |
| YoY Growth | N/A |
Balance Sheet
| Q3 2025 | |
|---|---|
| Assets | $84.5M |
| Liabilities | $10.7M |
| Equity | $-183.1M |
Cash Flow
No data available for this period